MedPath

Developmental assessment and stimulation of children at risk

Not Applicable
Conditions
child development, Depression Postpartum, parental stress, mother-child relationship, parental believes and practices on child care
F01.525.200
F01.145.126.990
C13.703.844.253
F01.829.263.370.290.170
I01.880.787.293.360
Registration Number
RBR-6ct969
Lead Sponsor
niversidade Federal de Minas Gerais/Prof. Claudia Regina Lindgren Alves
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

They will be admitted newborns included in the House of the Hospital Sofia Feldman baby during the period of conducting the survey; which remained for at least three days in the House of Baby; whose families are willing to participate in the stages of this project and signed the term of free and informed consent.

Exclusion Criteria

Children whose parents did not sign the consent form and clear; whose mothers died at birth; whose mothers have mental disorders that compromise their understanding or following your child; with diagnosed sensory disabilities; with malformation of the nervous system or the locomotor system; neurogenic diseases or chromosomal disorders diagnosed, the presence of hypoxic-ischemic lesions (multicystic encephalomalacia or periventricular leukomalacia) diagnosed.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Child Development evaluated by the total score in the Bayley Child Development Scale 3rd Edition (Bayley-III), applied at 4, 6, 9 and 12 months of age. Bayley-III is a standardized test with a mean score of 100 and a standard deviation of 15. Score lower than 1 standard deviation below the mean is suggestive of developmental delay. The test has 3 subscales to obtain measures of language, motor and cognitive development. Controlling for the initial performance level, it is expected that at the end of the study: (a) the intervention group will present mean scores in each area significantly higher than the controls, and (b) statistical modeling should indicate a lower chance of developmental delay, in the different areas, in the intervention group.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath